According to recent meta-analytic findings, certain polymorphisms in SLC6A2, such as rs28386840, may influence individual variability in response to MPH treatment in patients with ADHD [43]. This evidence concerns the gene SLC6A2 and attention deficit-hyperactivity disorder.